Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - eric+schopf
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
EGFRvIII Antibodies for the Treatment of Human Cancer
Abstract: Epidermal growth factor receptor variant III (EGFRvIII) is a variant of EGFR that is an excellent target for immunotherapy because of its expression in cancer cells and not in normal cells. Inventors from the National Cancer Institute (NCI) have isolated seven mouse monoclonal antibodies that bind to the human EGFRvIII but not wildtype EGFR....
Published: 4/8/2024
|
Inventor(s):
David Fitzgerald
,
Antonella Antignani
,
Eric Ho
,
Robert Sarnovsky
Keywords(s):
ADC
,
Antibody-drug Conjugate
,
CAR
,
chimeric antigen receptor
,
EGFR
,
EGFRvIII
,
Epidermal Growth Factor Receptor
,
Epidermal growth factor receptor variant III
,
FitzGerald
,
Recombinant Immunotoxins
,
RITs
Category(s):
Application > Therapeutics
,
TherapeuticArea > Oncology
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
2017-210 AUTOMATED PURIFICATION AND FORMULATION MODULE FOR PET PROBES
INTRO SENTENCE: Sofie Biosciences and UCLA researchers from the Department of Molecular and Medical Pharmacology have developed a novel automated module that purifies and formulates radiolabeled compounds intended for medical use. This automation reduces labor cost and radiation exposure, and is widely applicable.TITLE: Automated Purification...
Published: 7/19/2023
|
Inventor(s):
R. Michael Van Dam
,
Melissa Moore
,
Eric Schopf
,
Brandon Maraglia
,
Alexander Hsiao
Keywords(s):
Category(s):
Medical Devices > Medical Imaging > PET